On the 18th, the National Medical Insurance Bureau announced
The latest version of the National Medical Insurance Drug Catalog
111 new drugs included in the catalog
Among them, 7 drugs for rare diseases were included in the new catalog through negotiation
Spinal Muscular Atrophy (SMA)
It is a rare disease with high mortality and disability
Last year, SMA treatment drug Noxinargen Sodium
Enter the catalog by negotiating a price reduction
Allow SMA patients from the medical insurance drug list
"There is no medicine available" becomes "There is medicine available"
This year, a SMA oral drug
Also included in the catalog through negotiation
Let patients with rare diseases start from "having medicines available"
Become "medicine optional"
↓↓↓
"Drugs are administered to patients
value will not be underestimated”
"Still working harder"
"Please ask again, for the children with SMA"
Negotiation site
Tang Huilin, negotiator of the National Medical Insurance Bureau
Repeatedly discuss the price with the enterprise negotiator
After the price of 4500 yuan per bottle was rejected
Business representatives have spoken of drugs being undervalued
Tang Huilin said bluntly
"When medicines are used in patients, their value will not be underestimated.
If it is not used on the patient
No matter how good the medicine is, no matter how expensive the medicine is
It's all just sitting in the warehouse or on the production line
effect on patients
That’s where the value of medicine lies.”
Subsequently, business representatives left several times
Call for instructions and feedback the latest quotation
"We did our best"
"Long phone call with headquarters"
After the enterprise representative lowered the quotation to 3850 yuan
Medicare negotiators said
"You give these children some more money
They may just drink a few more bottles of milk
Eat more eggs for more nutrition
Our company also has feelings”
In the end, as the representatives of the enterprises left for the fourth time to negotiate
Confirm new offer
Both sides reached an agreement
The negotiations are over
Tang Huilin expressed her gratitude to the enterprise negotiators
"I think our hard work and sincerity are worth it
Allowing children with rare diseases to have more choices
On behalf of children with SMA, thank you”
Why are companies willing to cut prices into medical insurance?
It is understood that this year through negotiations
Drugs included in the medical insurance catalog
105 of them were approved for listing in the past five years
Among them, 23 drugs were just approved for marketing last year
Why companies are willing to cut prices into medical insurance?
Deputy Director of the Medical Service Management Department of the National Medical Insurance Administration
Huang Xinyu introduces medicines for rare diseases into medical insurance
It is a win-win for patients, medical insurance and enterprises
▌Source of this article: CCTV News WeChat Official Account (ID: cctvnewscenter)
Producer/Editor-in-Chief Xu Bing/Ma Wenjia
Main Station Reporter/Zhang Ping Zheng Yizhe
Editor / Lin Xiangyu